Writing Effective Introductions and Abstracts

1,302 views

Published on

Session Three of Scientific Writing Series

0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,302
On SlideShare
0
From Embeds
0
Number of Embeds
52
Actions
Shares
0
Downloads
54
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Writing Effective Introductions and Abstracts

  1. 1. Writing Effective Introductions and Abstracts Presented by: Wayne Loftus, MLS, Bio-Medical Library Mary Knatterud, PhD, Department of Surgery April 27, 2007 Office of Clinical Research
  2. 2. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Brenda Hudson Disclosure Information April 27, 2007
  3. 3. <ul><li>Key terms Wayne Loftus </li></ul><ul><li>Overview Mary Knatterud </li></ul><ul><li>Hands-on exercise Mary Knatterud </li></ul><ul><li>Q&A </li></ul>Office of Clinical Research Agenda
  4. 4. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Wayne Loftus Disclosure Information April 27, 2007
  5. 5. <ul><li>Information that’s hard to find will </li></ul><ul><li>remain information that’s hardly found. </li></ul><ul><li>- Peter Morville </li></ul>
  6. 6. <ul><li>find·a·bil·i·ty n </li></ul>a. The quality of being locatable or navigable. c. The degree to which a system or environment supports navigation and retrieval. b. The degree to which a particular object is easy to discover or locate.
  7. 9. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Mary Knatterud Disclosure Information April 27, 2007
  8. 10. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Mary Knatterud Disclosure Information April 27, 2007
  9. 11. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Mary Knatterud Disclosure Information April 27, 2007
  10. 12. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Mary Knatterud Disclosure Information April 27, 2007
  11. 13. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Mary Knatterud Disclosure Information April 27, 2007
  12. 14. <ul><li>I will not discuss off label use and/or investigational use in my presentation. </li></ul><ul><li>I have no financial relationships to disclose. </li></ul>Office of Clinical Research Mary Knatterud Disclosure Information April 27, 2007
  13. 15. <ul><li>Useful format: </li></ul><ul><li>Background </li></ul><ul><li>Methods </li></ul><ul><li>Results </li></ul><ul><li>Conclusions </li></ul>Office of Clinical Research Abstract
  14. 16. <ul><li>Use active voice End background section with hypothesis Cover the high points of your results Conclude with 1 or 2 sentences </li></ul>Office of Clinical Research Abstract
  15. 17. <ul><li>Three Paragraphs: 1 st : state the general problem 2 nd : outline the specific problem 3 rd : state the type of study it was and the hypothesis </li></ul>Office of Clinical Research Introduction

×